News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Skye Bioscience Reverse Stock Split to Be Effective on September 8th
September 7, 2023
·
4 min read
Satellos Bioscience Enters Into an Agreement with ICP Securities Inc. to Provide Market Making Services
September 7, 2023
·
7 min read
Therma Bright Submits Updated FDA 510K Application Requesting Correction of Venowave Device’s Intended Use, Labeling, and Description
September 7, 2023
·
3 min read
MustGrow and Janssen PMP, a division of Janssen Pharmaceutica NV, Announce Significant Project Expansion
September 6, 2023
·
9 min read
Drug Development
Awakn Life Sciences Submits Clinical Trial Application for Phase III Trial of AWKN-P001
September 6, 2023
·
7 min read
FDA
Izotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate Devices
September 6, 2023
·
8 min read
Business
PharmaDrug Announces Appointment of CEO and Changes to the Board of Directors
September 6, 2023
·
7 min read
Business
BioHarvest Announces August 2023 U.S. VINIA Sales Exceeded USD $1Million
September 6, 2023
·
4 min read
Policy
Telo Genomics Achieves Noteworthy International Standards Organization (“ISO”) Regulatory Accreditation
September 6, 2023
·
4 min read
Sona to Engage with Medical Experts and Payors to Inform Regulatory and Commercialization Strategies for Its ‘THT’ Cancer Therapy
September 5, 2023
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us